Matches in Wikidata for { <http://www.wikidata.org/entity/Q83261907> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q83261907 description "artículu científicu espublizáu en marzu de 2011" @default.
- Q83261907 description "im März 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83261907 description "scientific article published on 01 March 2011" @default.
- Q83261907 description "wetenschappelijk artikel" @default.
- Q83261907 description "наукова стаття, опублікована в березні 2011" @default.
- Q83261907 name "Anti-CD25 antibodies (daclizumab) as renal sparing immunosuppression after liver transplantation" @default.
- Q83261907 name "Anti-CD25 antibodies (daclizumab) as renal sparing immunosuppression after liver transplantation" @default.
- Q83261907 type Item @default.
- Q83261907 label "Anti-CD25 antibodies (daclizumab) as renal sparing immunosuppression after liver transplantation" @default.
- Q83261907 label "Anti-CD25 antibodies (daclizumab) as renal sparing immunosuppression after liver transplantation" @default.
- Q83261907 prefLabel "Anti-CD25 antibodies (daclizumab) as renal sparing immunosuppression after liver transplantation" @default.
- Q83261907 prefLabel "Anti-CD25 antibodies (daclizumab) as renal sparing immunosuppression after liver transplantation" @default.
- Q83261907 P1433 Q83261907-B4246776-1FF2-44D2-81B7-057C6C755733 @default.
- Q83261907 P1476 Q83261907-DD2B4EDA-4534-48D7-BAE9-59CD88C122FD @default.
- Q83261907 P2093 Q83261907-1DAFF024-FE56-466B-8D01-7E85F7812DEB @default.
- Q83261907 P2093 Q83261907-26DB427B-E066-4B48-B99F-F3DD6A244DA9 @default.
- Q83261907 P2093 Q83261907-46EB019D-AAC5-4C74-8FDA-C4CA85E7F4E6 @default.
- Q83261907 P2093 Q83261907-5087AB5F-7C3A-4C26-B1E2-3A11CC5263D0 @default.
- Q83261907 P2093 Q83261907-5AAA7B72-98C7-4E28-AB81-9D5878270A7F @default.
- Q83261907 P2093 Q83261907-6FD1EDD5-452D-4E16-9E8A-0D209B32D6E8 @default.
- Q83261907 P2093 Q83261907-B99C4204-5EBD-475D-AD7E-C9AF3F7EB200 @default.
- Q83261907 P304 Q83261907-AEADFB64-7338-426C-80B5-A92BECEE497E @default.
- Q83261907 P31 Q83261907-F6E41549-BAE5-484E-86B8-B0082D1298C5 @default.
- Q83261907 P356 Q83261907-5C872668-508F-403B-B347-2F5573FC9F9F @default.
- Q83261907 P433 Q83261907-D7AA28B7-1EA7-4D8D-918A-30A044C7FFD7 @default.
- Q83261907 P478 Q83261907-86E13436-6DB2-4C99-9EBA-770EAF7A0316 @default.
- Q83261907 P577 Q83261907-798A743D-B7DA-4089-86E4-5D0BD4953431 @default.
- Q83261907 P698 Q83261907-8A655CBA-2510-4583-8F9B-40CADCDBAC0C @default.
- Q83261907 P356 J.1365-2036.2010.04551.X @default.
- Q83261907 P698 21255044 @default.
- Q83261907 P1433 Q4726656 @default.
- Q83261907 P1476 "Anti-CD25 antibodies (daclizumab) as renal sparing immunosuppression after liver transplantation" @default.
- Q83261907 P2093 "A Alakkari" @default.
- Q83261907 P2093 "A Watson" @default.
- Q83261907 P2093 "D Maguire" @default.
- Q83261907 P2093 "J E Hegarty" @default.
- Q83261907 P2093 "J Geoghegan" @default.
- Q83261907 P2093 "O Traynor" @default.
- Q83261907 P2093 "P A McCormick" @default.
- Q83261907 P304 "615-6; author reply 616-7" @default.
- Q83261907 P31 Q13442814 @default.
- Q83261907 P356 "10.1111/J.1365-2036.2010.04551.X" @default.
- Q83261907 P433 "5" @default.
- Q83261907 P478 "33" @default.
- Q83261907 P577 "2011-03-01T00:00:00Z" @default.
- Q83261907 P698 "21255044" @default.